7.15 Delayed Data As of Apr 24 | ![]() Today’s Change | 6.71 Today|||52-Week Range 11.93 | -12.80% Year-to-Date |
Previous close | 7.01 |
Today’s open | 6.98 |
Day’s range | 6.98 - 7.18 |
Volume | 283,490 |
Average volume (3 months) | 413,340 |
Market cap | $289.9M |
Earnings growth (last year) | -- |
Earnings growth (this year) | -473.39% |
Earnings growth (next 5 years) | +2.00% |
Revenue growth (last year) | +16.26% |
P/E ratio | 4.4 |
Price/Sales | 1.97 |
Price/Book | 3.39 |
Today’s change | Today’s % change | |
---|---|---|
IOVAIovance Biotherapeut... | -0.15 | -1.03% |
GLYCGlycoMimetics Inc | -0.94 | -5.30% |
TLGTTeligent Inc | +0.05 | +1.46% |
DEPODepomed Inc | +0.04 | +0.59% |
Next reporting date | May 8, 2018 |
EPS forecast (this quarter) | -$0.28 |
Annual revenue (last year) | $174.2M |
Annual profit (last year) | $67.8M |
Net profit margin | 38.93% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Michael Shannon Anderson |
Chief Operating Officer & Executive Vice President Gregory J. Divis |
Corporate headquarters Dublin, Dublin |